Hypertension, Vol 5, 689-700, Copyright © 1983 by American Heart Association
KH Berecek, T Okuno, S Nagahama and S Oparil
Previous studies from our laboratory have shown that chronic
intracerebroventricular administration of captopril attenuates the
development of hypertension in the spontaneously hypertensive rat of the
Okamoto strain (SHR) without altering sodium and water balance, plasma
renin, or sympathoadrenal activities. To determine whether the depressor
effect of intracerebroventricular captopril was associated with an
alteration in peripheral vascular reactivity and/or baroreflex sensitivity,
vascular reactivity to phenylephrine and vasopressin was assessed in renal,
mesenteric, and hindquarter vascular beds using pulsed Doppler flow probes.
Captopril was infused into the jugular vein or lateral ventricle of male
SHR and Wistar-Kyoto (WKY) rats for 4 weeks (osmotic mini pump, 1.25
micrograms/0.5 microliter/hr). Control SHR or WKY received
intracerebroventricular infusions of vehicle. Four weeks of captopril
decreased arterial pressure in both SHR and WKY. In response to
phenylephrine and vasopressin, SHR and WKY treated with
intracerebroventricular captopril showed significantly attenuated increases
in arterial pressure and vascular resistance in comparison to either
vehicle-treated rats or rats receiving intravenous captopril. Reflex
decreases in heart rate in response to phenylephrine were also greater in
SHR and WKY treated with intracerebroventricular captopril than in the
other rat groups. Neither vascular reactivity nor baroreflex sensitivity
was altered in rats treated with intravenous captopril. We conclude that
the depressor effect of captopril involves a blunting of vascular
reactivity to vasoconstrictors and a potentiation of the baroreflex.
ARTICLES
Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat
This article has been cited by other articles:
![]() |
U. C. Kopp and M. Z. Cicha Impaired substance P release from renal sensory nerves in SHR involves a pertussis toxin-sensitive mechanism Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R326 - R333. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Britto, R. A. S. Santos, C. R. Fagundes-Moura, M. C. Khosla, and M. J. Campagnole-Santos Role of Angiotensin-(1-7) in the Modulation of the Baroreflex in Renovascular Hypertensive Rats Hypertension, September 1, 1997; 30(3): 549 - 556. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |